blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1293202

EP1293202 - REMEDIES FOR DEGENERATIVE ARTHRITIS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.01.2007
Database last updated on 19.07.2024
Most recent event   Tooltip26.01.2007Application deemed to be withdrawnpublished on 28.02.2007  [2007/09]
Applicant(s)For all designated states
ONO PHARMACEUTICAL CO., LTD.
1-5, Doshomachi 2-chome Chuo-ku
Osaka-shi, Osaka 541-8526 / JP
[N/P]
Former [2003/12]For all designated states
ONO PHARMACEUTICAL CO., LTD.
1-5, Doshomachi 2-chome, Chuo-ku
Osaka-shi, Osaka 541-8526 / JP
Inventor(s)01 / MAEDA, Yoshizou Minase Res.Inst. ONO Pharma.Co.Ltd
1-1, Sakurai 3-chome, Shimamotocho
Mishima-gun, Osaka 618-8585 / JP
02 / YONETOMI, Yasuo Minase Res.Inst. ONO Pharma.Co.Ltd
1-1, Sakurai 3-chome, Shimamotocho
Mishima-gun, Osaka 618-8585 / JP
03 / OGAWA, Koji Minase Res. Inst. ONO Pharma. Co. Ltd
1-1, Sakurai 3-chome, Shimamotocho
Mishima-gun, Osaka 618-8585 / JP
 [2003/12]
Representative(s)Henkel & Partner mbB
Patentanwaltskanzlei, Rechtsanwaltskanzlei
Maximiliansplatz 21
80333 München / DE
[N/P]
Former [2003/12]Henkel, Feiler, Hänzel
Möhlstrasse 37
81675 München / DE
Application number, filing date01904367.809.02.2001
[2003/12]
WO2001JP00914
Priority number, dateJP2000003342210.02.2000         Original published format: JP 2000033422
[2003/12]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0158440
Date:16.08.2001
Language:EN
[2001/33]
Type: A1 Application with search report 
No.:EP1293202
Date:19.03.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 16.08.2001 takes the place of the publication of the European patent application.
[2003/12]
Search report(s)International search report - published on:JP16.08.2001
(Supplementary) European search report - dispatched on:EP08.11.2004
ClassificationIPC:A61K31/166, A61P19/02
[2003/12]
CPC:
A61K31/166 (EP,KR,US); A61P19/02 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/12]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:HEILMITTEL FÜR DEGENERATIVE ARTHRITIS[2003/12]
English:REMEDIES FOR DEGENERATIVE ARTHRITIS[2003/12]
French:MEDICAMENTS POUR LE TRAITEMENT DE L'ARTHRITE DEGENERATIVE[2003/12]
Entry into regional phase07.08.2002Translation filed 
07.08.2002National basic fee paid 
07.08.2002Search fee paid 
07.08.2002Designation fee(s) paid 
07.08.2002Examination fee paid 
Examination procedure09.08.2001Request for preliminary examination filed
International Preliminary Examining Authority: JP
07.08.2002Examination requested  [2003/12]
25.08.2006Despatch of a communication from the examining division (Time limit: M02)
01.09.2006Application deemed to be withdrawn, date of legal effect  [2007/09]
11.10.2006Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2007/09]
Fees paidRenewal fee
27.02.2003Renewal fee patent year 03
26.02.2004Renewal fee patent year 04
25.02.2005Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
28.02.200606   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9718188  (ABBOTT LAB [US]);
 [PX]  - YAMADA A AND ALL., "ONO-4817, an orally active matrix metalloproteinase inhibitor, prevents lipopolysaccharide-induced proteoglycan release from the joint cartilage in guinea pigs", INFLAMMATION RESEARCH, (200004), vol. 49, no. 4, pages 144 - 146, XP002302945 [PX] 1 * abstract *

DOI:   http://dx.doi.org/10.1007/s000110050573
International search[Y]WO9919296  (ONO PHARMACEUTICAL CO [JP], et al);
 [Y]EP0935963  (PFIZER PROD INC [US]);
 [Y]WO9951572  (SANKYO CO [JP], et al);
 [Y]  - E.M. O'BYRNE ET AL., "Oral administration of a matrix metallo proteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteo arthritis in rabbit", INFLAMM. RES., vol. 44, no. SUPPLEMENT 2, pages S117 - S118, XP002941588

DOI:   http://dx.doi.org/10.1007/BF01778290
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.